0000902664-21-004070.txt : 20210830
0000902664-21-004070.hdr.sgml : 20210830
20210830193633
ACCESSION NUMBER: 0000902664-21-004070
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210826
FILED AS OF DATE: 20210830
DATE AS OF CHANGE: 20210830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Avoro Capital Advisors LLC
CENTRAL INDEX KEY: 0001633313
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38560
FILM NUMBER: 211225033
BUSINESS ADDRESS:
STREET 1: 110 GREENE STREET
STREET 2: SUITE 800
CITY: NEW YORK
STATE: NY
ZIP: 10012
BUSINESS PHONE: 212-937-4975
MAIL ADDRESS:
STREET 1: 110 GREENE STREET
STREET 2: SUITE 800
CITY: NEW YORK
STATE: NY
ZIP: 10012
FORMER NAME:
FORMER CONFORMED NAME: venBio Select Advisor LLC
DATE OF NAME CHANGE: 20150210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Avoro Ventures LLC
CENTRAL INDEX KEY: 0001879253
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38560
FILM NUMBER: 211225032
BUSINESS ADDRESS:
STREET 1: 110 GREEN STREET, SUITE 800
CITY: NEW YORK
STATE: NY
ZIP: 10012
BUSINESS PHONE: (212) 937-4975
MAIL ADDRESS:
STREET 1: 110 GREEN STREET, SUITE 800
CITY: NEW YORK
STATE: NY
ZIP: 10012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aghazadeh Behzad
CENTRAL INDEX KEY: 0001701815
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38560
FILM NUMBER: 211225034
MAIL ADDRESS:
STREET 1: C/O AVORO CAPITAL ADVISORS LLC
STREET 2: 110 GREENE STREET, SUITE 800
CITY: NEW YORK
STATE: NY
ZIP: 10012
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aadi Bioscience, Inc.
CENTRAL INDEX KEY: 0001422142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611547850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 17383 SUNSET AVENUE
STREET 2: SUITE A250
CITY: PACIFIC PALISADES
STATE: CA
ZIP: 90272
BUSINESS PHONE: 424-473-8055
MAIL ADDRESS:
STREET 1: 17383 SUNSET AVENUE
STREET 2: SUITE A250
CITY: PACIFIC PALISADES
STATE: CA
ZIP: 90272
FORMER COMPANY:
FORMER CONFORMED NAME: Aerpio Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20170316
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA ACQUISITION CORP II
DATE OF NAME CHANGE: 20071227
3
1
ownership.xml
X0206
3
2021-08-26
0
0001422142
Aadi Bioscience, Inc.
AADI
0001701815
Aghazadeh Behzad
C/O AVORO CAPITAL ADVISORS LLC
110 GREENE STREET, SUITE 800
NEW YORK
NY
10012
1
0
0
1
See Remarks
0001633313
Avoro Capital Advisors LLC
110 GREENE STREET
SUITE 800
NEW YORK
NY
10012
1
0
0
1
See Remarks
0001879253
Avoro Ventures LLC
110 GREENE STREET, SUITE 800
NEW YORK
NY
10012
1
0
0
1
See Remarks
Common Stock, par value $0.0001 per share
300000
I
See footnotes
The securities reported herein are held on behalf of accounts managed by Avoro Capital Advisors LLC, a Delaware limited liability company ("Avoro Capital Advisors"). Behzad Aghazadeh ("Dr. Aghazadeh") serves as the portfolio manager and controlling person of Avoro Capital Advisors and Avoro Ventures LLC, a Delaware limited liability company ("Avoro Ventures", and together with Avoro Capital Advisors and Dr. Aghazadeh, the "Reporting Persons").
The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
Avoro Capital Advisors and Avoro Ventures may be deemed directors by deputization of the Issuer by virtue of the fact that Dr. Aghazadeh currently serves on the board of directors of the Issuer.
Avoro Capital Advisors LLC, by: /s/ Scott Epstein, its Chief Financial Officer & Chief Compliance Officer
2021-08-30
Avoro Ventures LLC, by: /s/ Scott Epstein, its Chief Financial Officer & Chief Compliance Officer
2021-08-30
/s/ Behzad Aghazadeh
2021-08-30